EPFL scientists have developed ways to make chemical modifications to huntingtin protein, bypassing the need to identify the enzymes behind them
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
We’ve all been told that next generation sequencing is revolutionising healthcare. But how is it actually being applied, today?
A new study suggests that while more low-risk women are being screened, BRCA testing may well be underused for high-risk people
A study has correlated 80 cancer- and leukaemia-related genes to five subtypes of acute myeloid leukaemia (AML) in newly diagnosed, adult patients
Poly ADP Ribose Polymerase (PARP) inhibitors, currently used to treat some breast cancers may be more widely effective, new research has found
Brandi Davis-Dusenbery will be taking over the role of CEO at Seven Bridges as former CEO Deniz Kural moves to a new Board position
Paediatric geneticist David Flannery became ACMG Medical Director in 2014, bringing with him unique expertise in healthcare economics and genetic services
More than 90 genomics researchers gathered to launch QGP’s research consortium, the largest project of its kind in Qatar